Entrada Therapeutics (TRDA) Tax Rate (2023 - 2026)

Entrada Therapeutics' Tax Rate history runs 4 years deep, the most recent figure standing at 0.1% for Q1 2026.

• On a quarterly basis, Tax Rate changed N/A year-over-year to 0.1% in Q1 2026; TTM through Mar 2026 was 0.6%, a 331.0% increase from a year earlier, with the FY2025 full-year figure at 0.63%, down 192.0% from the prior year.
• Tax Rate advanced to 0.1% in Q1 2026 per TRDA's latest filing, from 0.26% in the prior quarter.
• Across five years, Tax Rate topped out at 253.04% in Q4 2024 and bottomed at 114.62% in Q2 2023.
• The 4-year median for Tax Rate is 0.18% (2026), against an average of 12.76%.
• Across the five-year window, Tax Rate surged 12093 bps in 2024 and slumped 25330 bps in 2025, its largest moves.
• Year by year, Tax Rate stood at 203.33% in 2023, then rose by 24 bps to 253.04% in 2024, then slumped by 100 bps to 0.26% in 2025, then soared by 63 bps to 0.1% in 2026.
• Per Business Quant, the three latest TRDA Tax Rate figures stand at 0.1% (Q1 2026), 0.26% (Q4 2025), and 1.5% (Q3 2025).